Clinical Trial Update: Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating acetylsalicylic acid for prevention of severe COVID-19 pneumonia in hospitalized patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Thrombosis

Drugs mentioned

• Acetylsalicylic acid (Aspirin)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: COVID-19, Thrombosis Pulmonary | Phase 3 | Status: UNKNOWN